Adia Nutrition (ADIA) Cash from Financing Activities (2025 - 2026)
Adia Nutrition's (ADIA) quarterly Cash from Financing Activities came in at $117855.0 in Q1 2026, up 81.01% year-over-year from $65109.0 in Q1 2025, and up 81.01% quarter-over-quarter from $65109.0 in Q1 2025.
Powered by 
Analysis
Adia Nutrition (ADIA) Cash from Financing Activities (2025 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Cash from Financing Activities for 2 consecutive years, with $117855.0 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 15.05 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 7.18 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 49.29 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 167.70 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 249.12 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | -33,000.00 |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 7.52 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 2.69 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |